Potential impact of omega-3 treatment on cardiovascular disease in type 2 diabetes
Hartweg J., Farmer AJ., Holman RR., Neil A.
This systematic review and meta-analysis confirms the triglyceride lowering effects of omega-3 PUFAs, demonstrates potential dose-response effects and shows improvements in thrombogenesis. Omega-3 PUFAs raise LDL levels without concomitant changes in lipid particle size. Changes seen in conventional risk factors are insufficient to explain the cardiovascular disease risk reductions suggested to occur with omega-3 PUFAs. © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins. cardiovascular disease, docosahexaenoic acid, eicosapentaenoic acid, omega-3 polyunsaturated fatty acids, type 2 diabetes.